UB
REGN icon

Umpqua Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Umpqua Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Buy
2,271
+205
+10% +$140K 0.32% 72
2026
Q1 		$1.6M Buy
2,066
+108
+6% +$82.7K 0.46% 60
2025
Q4 		$1.51M Sell
1,958
-261
-12% -$177K 0.42% 66
2025
Q3 		$1.28M Buy
2,219
+74
+3% +$41.8K 0.36% 74
2025
Q2 		$1.17M Buy
2,145
+314
+17% +$175K 0.36% 75
2025
Q1 		$1.16M Buy
1,831
+297
+19% +$204K 0.4% 69
2024
Q4 		$1.06M Buy
1,534
+108
+8% +$90.6K 0.37% 73
2024
Q3 		$1.5M Buy
1,426
+32
+2% +$35.6K 0.55% 52
2024
Q2 		$1.47M Buy
1,394
+82
+6% +$79.5K 0.57% 49
2024
Q1 		$1.26M Buy
+1,312
New +$1.25M 0.52% 59

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Umpqua Bank's REGN Position: Q2 2026 in Review

Umpqua Bank increased its Regeneron Pharmaceuticals (REGN) stake by 9.9% in Q2 2026, buying an estimated $140K and bringing the position to 2,271 shares worth $1.42M. The position accounts for 0.32% of the portfolio, ranked #72.

Umpqua Bank first reported a position in REGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.6M in Q1 2026. 1,316 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Umpqua Bank held 2,271 shares of Regeneron Pharmaceuticals worth $1.42M as of Q2 2026.
  • Umpqua Bank bought 205 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $140K.
  • Regeneron Pharmaceuticals made up 0.32% of Umpqua Bank's portfolio in Q2 2026, its #72 holding.
  • Umpqua Bank first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Umpqua Bank's Regeneron Pharmaceuticals position peaked at $1.6M in Q1 2026.
  • 1,316 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Umpqua Bank's 13F filing for Q2 2026, filed 24 Jul 2026.